In the case of PCa, it is known that the progression to the fatal stage of the disease, ablation resistance, depends to a large degree on the activity of the AR [12]–[16], a potent transcription factor (TF) that facilitates epigenetic control of gene expression at many target loci across the entire human genome. The gene discussed is AR; the disease is posterior cortical atrophy.